24. Survival at predefined time points for all cancer patients*.

	On study mortality data set			Overall survival data set
Time after date of randomization	Deaths	ESA versus control HR (95% CI)**	P value	Deaths	ESA versus control HR (95% CI)*	P value
At 4 months	1193	1.13 (95% CI 1.01‐1.27)	0.036	1419	1.12 (95% CI 1.01‐1.24)	0.038
At 8 months	1425	1.16 (95% CI 1.04‐1.29)	0.006	2678	1.06 (95% CI 0.98‐1.14)	0.140
At 12 months	1507	1.17 (95% CI 1.06‐1.30)	0.002	3561	1.06 (95% CI 0.99‐1.14)	0.071
At 24 months	‐	‐	‐	4537	1.06 (95% CI 1.00‐1.13)	0.042
At 36 months	‐	‐	‐	4833	1.05 (95% CI 0.99‐1.12)	0.075
At 60 months	‐	‐	‐	4977	1.06 (95% CI 1.00‐1.12)	0.043

*13933 patients from all treatment populations were under observation. 
 **based on Cox fixed‐effects model stratified by study